Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Colon cancer
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 39 for your search:
Start Over
Vitamin D/Calcium Polyp Prevention Study
Phase: Phase III, Phase II
Type: Prevention
Status: Closed
Age: 45 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 CA098286-03, 5R01CA098286-10, NCT00153816
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
Phase: Phase III
Type: Prevention
Status: Completed
Age: 30 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02327, 98-008, NYH-CMC-0298-108, SC-IQ4-99-02-005, CDR0000067750, NCI-P00-0141, STRANG-98-008, BWH-NO1-CN-95015, N01CN95015, NCT00005094
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Phase: Phase III
Type: Prevention
Status: Completed
Age: over 30 to under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000078380, CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527
Selenium for Prevention of Adenomatous Colorectal Polyps
Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000353185, P30CA023074, P01CA041108, UARIZ-00-0430-01, 00-0430-01, UARIZ-HSC-00142, NCT00078897
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Closed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2009-00880, UCI 97-05, R01CA088078, UCIRVINE-UCI-2002-2261, NCT00118365
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: CAPS08-15024, R01CA129488-01A2, NCT01052051
Phase I/II Chemoprevention Study of Eflornithine (DFMO) in Patients At Risk for Colorectal Carcinoma (Summary Last Modified 02/98)
Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-9221, NCI-P97-0096
Phase I/II Randomized Study of Celecoxib for Hereditary Nonpolyposis Colorectal Cancer Patients and Gene Carriers (Summary Last Modified 02/2001)
Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0087
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
Phase: Phase II
Type: Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000064180, E-8292, NCI-P95-0066, NCT00002650
Phase II Chemoprevention Study of Vitamin D3 and Calcium for Colorectal Cancer (Summary Last Modified 01/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
Phase II Clinical Trial of Sulindac, a Nonsteroidal Antiinflammatory Agent, for Chemoprevention of Colorectal Neoplasia (Summary Last Modified 05/1999)
Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: CPMC-IRB-1095-072, NCI-P97-0110
Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000069498, NCI-02-C-0194, NCT00043043
Calcium and Vitamin D vs Markers of Adenomatous Polyps
Phase: Phase II
Type: Prevention
Status: Completed
Age: 30 to 74
Sponsor: NCI, Other
Protocol IDs: 0126-2004, R01CA104637, NCT00208793
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00837, CDR0000467755, MAY03-1-03, N01CN35000, P30CA015083, MAYO-030103, MAYO-1395-05, NCT00335504
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00449, UIC-2005-0617, CDR0000483003, UCIRVINE-2005-4586, UIC HS# 2005-0617, CCUM-HUM00000731, P30CA062203, 2005-0617, UCI04-2-01, N01CN35160, UCIRVINE-UCI04-2-01, NCT00365209
Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01113, NCI 06-8-01, CDR0000632553, N01CN35157, NWU06-8-01, P30CA060553, NU-NWU06-8-01, NCT00828984
Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 70
Sponsor: NCI, Other
Protocol IDs: PRO07030214, NCT00773097
Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients With Benign Colorectal Polyps
Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000067922, 1997-96, NCI-P00-0150, UCIRVINE-97-05, NCT00005882
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: NCI-2009-00841, CDR0000652929, NCI 04-2-03, NWU04-2-03, N01CN35157, NU-NWU04-2-03, NCT00468910
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 69
Sponsor: NCI, Other
Protocol IDs: 00039278, P01CA073992, NCT01187901
A Trial of Metformin for Colorectal Cancer Risk Reduction Among Patients With a History of Colorectal Adenomas and Elevated Body Mass Index
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 80
Sponsor: NCI
Protocol IDs: NCI-2011-01744, UCI 10-31, 2010-7705, UCI09-13-01, P30CA062203, N01CN35160, NCT01312467
Phase I Study of Oltipraz Given Twice Weekly as Prevention for Colorectal Cancer (Summary Last Modified 03/98)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-91059, NCI-P97-0091
Start Over